Shumpei Obata Taku Imamura Masashi Kakinoki Takahide Yanagi Yoshihiro Maruo Masahito Ohji
10.1371/journal.pone.0256878
PLoS One
2021 Sep 9;16(9):e0256878.
CC BY
https://pubmed.ncbi.nlm.nih.gov/34499693/
Drug-Related Side Effects and Adverse Reactions / diagnosis Mass Screening Mydriatics / adverse effects Retinopathy of Prematurity / diagnosis
Drug-Related Side Effects and Adverse Reactions / diagnosis Mass Screening Mydriatics / adverse effects Retinopathy of Prematurity / diagnosis Research Support, Non-U.S. Gov't Body Weight Drug-Related Side Effects and Adverse Reactions / epidemiology Drug-Related Side Effects and Adverse Reactions / pathology Female Gestational Age Humans Infant Infant, Newborn Infant, Premature Male Medical Records Mydriatics / administration & dosage Ophthalmic Solutions / administration & dosage Ophthalmic Solutions / adverse effects Phenylephrine / administration & dosage Phenylephrine / adverse effects Retinopathy of Prematurity / complications Retinopathy of Prematurity / epidemiology Retinopathy of Prematurity / pathology Tropicamide / administration & dosage Tropicamide / adverse effects Mydriatics Ophthalmic Solutions Phenylephrine Tropicamide
PMC8428556
34499693
Systemic adverse events after screening of retinopathy of prematurity with mydriatic
2021